xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.subject_decs
Ara mostrant els elements 1-5 d 5
-
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
(Wolters Kluwer Health, 2021-11-09) -
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
(Lippincott Williams & Wilkins, 2021-06-24) -
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
(Lippincott, Williams & Wilkins, 2022-11)